Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Dec 10, 2025 · Filed Dec 11, 2025
A board member of TransDigm Group sold $748K of TransDigm Group shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$747,805
Shares × reported transaction price
28 days after results of Nov 12, 2025, 55 days before results of Feb 3, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1,302.90 on Dec 10, 2025, 6% above its 52-week low and 20% below its high, after a 2% drop over the previous 30 trading days
52-week range $1,231.75 (Apr 8, 2025) to $1,620.83 (Jul 30, 2025), 18% of the way up, from 250 adjusted closes. 30 trading days earlier: $1,335.12 on Oct 28, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -1.4% | -0.2% | -1.2% |
| 30 days | +7.1% | +2.0% | +5.1% |
| 90 days | -5.3% | -2.3% | -3.0% |
| 180 days | -6.4% | +6.4% | -12.8% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
A board member of TransDigm Group sold $8.97M of TransDigm Group shares. Nobody planned it ahead of time.
A board member of TransDigm Group sold $1.8M of TransDigm Group shares. Nobody planned it ahead of time.